Regulatory Compliance Articles

The Food and Drug Administration approved Aprotinin in 1993, a drug marketed by Bayer as Trasylol. Until being withdrawn from the market, sales of Trasylol over the past several years had escalated to more than $600 million. Unfortunately, there are